Literature DB >> 8636426

A somatically mutated human antiganglioside IgM antibody that induces experimental neuropathy in mice is encoded by the variable region heavy chain gene, V1-18.

H J Willison1, G M O'Hanlon, G Paterson, J Veitch, G Wilson, M Roberts, T Tang, A Vincent.   

Abstract

IgM paraproteins associated with autoimmune peripheral neuropathy and anti-Pr cold agglutinins react with sialic acid epitopes present on disialylated gangliosides including GD1b, GT1b, GQ1b, and GD3. A causal relationship between the paraprotein and the neuropathy has never been proven experimentally. From peripheral blood B cells of an affected patient, we have cloned a human hybridoma secreting an antidisialosyl IgM mAb, termed Ha1, that shows identical structural and functional characteristics to its serum counterpart. Variable region analysis shows Ha1 is encoded by the same VH1 family heavy chain gene, V1-18, as the only other known anti-Pr antibody sequence and is somatically mutated, suggesting that it [correction of is] arose in vivo in response to antigenic stimulation. In the rodent peripheral nervous system, Ha1 immunolocalizes to dorsal root ganglia, motor nerve terminals, muscle spindles, myelinated axons, and nodes of Ranvier. After intraperitoneal injection of affinity-purified antibody into mice for 10 d, electrophysiological recordings from the phrenic nerve-hemidiaphragm preparation demonstrated impairment of nerve excitability and a reduction in quantal release of neurotransmitter. These data unequivocally establish that an antidisialosyl antibody can exert pathophysiological effects on the peripheral nervous system and strongly support the view that the antibody contributes to the associated human disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8636426      PMCID: PMC507167          DOI: 10.1172/JCI118529

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  52 in total

1.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

2.  Acute conduction block in vitro following exposure to antiganglioside sera.

Authors:  K Arasaki; S Kusunoki; N Kudo; I Kanazawa
Journal:  Muscle Nerve       Date:  1993-06       Impact factor: 3.217

Review 3.  Gangliosides and modulation of the function of neural cells.

Authors:  G Tettamanti; L Riboni
Journal:  Adv Lipid Res       Date:  1993

4.  Peripheral neuropathy associated with monoclonal IgM anti-Pr2 cold agglutinins.

Authors:  H J Willison; G Paterson; J Veitch; G Inglis; S C Barnett
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-11       Impact factor: 10.154

Review 5.  Gangliosides and bacterial toxins in Guillain-Barré syndrome.

Authors:  H J Willison; P G Kennedy
Journal:  J Neuroimmunol       Date:  1993-07       Impact factor: 3.478

6.  Naturally occurring anti-i/I cold agglutinins may be encoded by different VH3 genes as well as the VH4.21 gene segment.

Authors:  L C Jefferies; C M Carchidi; L E Silberstein
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

Review 7.  Antiganglioside antibodies do not necessarily play a role in multifocal motor neuropathy.

Authors:  G J Parry
Journal:  Muscle Nerve       Date:  1994-01       Impact factor: 3.217

8.  Interaction of botulinum and tetanus toxins with the lipid bilayer surface.

Authors:  C Montecucco; G Schiavo; Z Gao; E Bauerlein; P Boquet; B R DasGupta
Journal:  Biochem J       Date:  1988-04-15       Impact factor: 3.857

Review 9.  Gangliosides as receptors for bacterial enterotoxins.

Authors:  P H Fishman; T Pacuszka; P A Orlandi
Journal:  Adv Lipid Res       Date:  1993

10.  A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure.

Authors:  N Yuki; T Taki; F Inagaki; T Kasama; M Takahashi; K Saito; S Handa; T Miyatake
Journal:  J Exp Med       Date:  1993-11-01       Impact factor: 14.307

View more
  15 in total

Review 1.  Relationship between autoantibody specificities and peripheral nervous system involvements.

Authors:  M O Jauberteau-Marchan
Journal:  Clin Rev Allergy Immunol       Date:  2000-08       Impact factor: 8.667

2.  Antiganglioside antibodies in peripheral neuropathies.

Authors:  A Vincent
Journal:  J Clin Pathol       Date:  1998-09       Impact factor: 3.411

Review 3.  Autoimmune responses in peripheral nerve.

Authors:  H P Hartung; H Willison; S Jung; M Pette; K V Toyka; G Giegerich
Journal:  Springer Semin Immunopathol       Date:  1996

4.  Monoclonal antibodies raised against Guillain-Barré syndrome-associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations.

Authors:  C S Goodyear; G M O'Hanlon; J J Plomp; E R Wagner; I Morrison; J Veitch; L Cochrane; R W Bullens; P C Molenaar; J Conner; H J Willison
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

5.  Guillain-Barré syndrome- and Miller Fisher syndrome-associated Campylobacter jejuni lipopolysaccharides induce anti-GM1 and anti-GQ1b Antibodies in rabbits.

Authors:  C W Ang; M A De Klerk; H P Endtz; B C Jacobs; J D Laman; F G van der Meché; P A van Doorn
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

Review 6.  Complex gangliosides as autoantibody targets at the neuromuscular junction in Miller Fisher syndrome: a current perspective.

Authors:  Graham M O'Hanlon; Roland W M Bullens; Jaap J Plomp; Hugh J Willison
Journal:  Neurochem Res       Date:  2002-08       Impact factor: 3.996

7.  Pupillary Involvement in Miller Fisher Syndrome.

Authors:  Bahar Kaymakamzade; Ferda Selcuk; Aydan Koysuren; Ayse Ilksen Colpak; Senem Ertugrul Mut; Tulay Kansu
Journal:  Neuroophthalmology       Date:  2013-05-31

8.  Anti-ganglioside complex antibodies in Miller Fisher syndrome.

Authors:  K Kaida; M Kanzaki; D Morita; K Kamakura; K Motoyoshi; M Hirakawa; S Kusunoki
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-04-13       Impact factor: 10.154

Review 9.  Antiganglioside antibodies and their pathophysiological effects on Guillain-Barré syndrome and related disorders--a review.

Authors:  Kenichi Kaida; Toshio Ariga; Robert K Yu
Journal:  Glycobiology       Date:  2009-02-24       Impact factor: 4.313

10.  Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients.

Authors:  C W Ang; J D Laman; H J Willison; E R Wagner; H P Endtz; M A De Klerk; A P Tio-Gillen; N Van den Braak; B C Jacobs; P A Van Doorn
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.